版本:
中国

BRIEF-EU approves Pfizer’s Trumenba to help prevent meningococcal group B disease in adolescents and adults

May 30 Pfizer Inc

* European commission approves pfizer’s trumenba® to help prevent meningococcal group b disease in adolescents and adults

* Pfizer inc says trumenba approved in europe with option for a two- or three-dose schedule Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐